Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
4,307
Funds Holding Change
+57
Funds Holding Growth
+1%
Value
$1.37T
Holding in Top 10
1,065
Top 10 Change
-53
Top 10 Growth
-5%
Value Growth
+0.8%
New
197
Increased
2,235
Reduced
1,668
Closed
83
Capital Inflow
$53.7B
Capital Outflow
$38.9B
Net Capital Flow
+$14.8B
Capital Flow Change
+$9.93B
Calls
$16.3B
Puts
$15.9B
Net Calls
+$369M
Put/Call Ratio
0.98